Trends in Glyburide Compared With Insulin Use for Gestational Diabetes Treatment in the United States, 2000–2011

Benefits and Risks of Oral Diabetes Agents Compared With Insulin in Women With Gestational Diabetes

(2014) Wanda Nicholson et al.   OBSTETRICS AND GYNECOLOGY

Effectiveness of gestational diabetes treatment: A systematic review with quality of evidence assessment

(2012) Maicon Falavigna et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG)

(2011) D. A. Ogunyemi et al.   DIABETIC MEDICINE

Validation of algorithms to ascertain clinical conditions and medical procedures used during pregnancy

(2011) Susan E. Andrade et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Diabetes Trends Among Delivery Hospitalizations in the U.S., 1994-2004

(2010) S. S. Albrecht et al.   DIABETES CARE

Glyburide in gestational diabetes – prediction of treatment failure

(2010) Yariv Yogev et al.   Journal of Maternal-Fetal & Neonatal Medicine

Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice

(2009) MF Hebert et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Estimating average annual per cent change in trend analysis

(2009) Limin X. Clegg et al.   STATISTICS IN MEDICINE

Reduced adaptation of the pancreatic B cells during pregnancy is the major causal factor for gestational diabetes: Current knowledge and metabolic effects on the offspring

(2008) Roland Devlieger et al.   ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA